Ibogaine, a psychedelic derived from the African iboga plant, is being promoted as a potential breakthrough treatment for opioid addiction and PTSD, with anecdotal reports of profound therapeutic effects. However, scientific evidence is limited, clinical trials show mixed results, and the
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Meryl Horn
conversational on Science Vs
Mentions
Books, people, and resources mentioned in this episode.
People
Topics
Listen to This Episode
More from Science Vs
Peptides: The Ultimate Body Hack?
Is Your Relationship … OK?
Caffeine: How Much is Too Much?
Weight Cycling: Is 'Yo-Yo Dieting' Dangerous?
Brian Can’t Stop Fact-Checking His Mother-in-Law
Narcissists: Are We Surrounded?
Related episodes
From other shows on similar topics.
One Reporter’s Life-Altering Psychedelic Trip
The Daily
How the right embraced psychedelics
Today, Explained
#2477 - Rick Perry & W. Bryan Hubbard
The Joe Rogan Experience
What Is Ibogaine and Why Is Trump Talking About It?
The Political Scene | The New Yorker
Rethinking addiction in the age of Ozempic
TED Radio Hour
Essentials: Psychedelics & Neurostimulation for Brain Rewiring | Dr. Nolan Williams
Huberman Lab
Get summaries like this every morning.
Free AI-powered recaps of Science Vs and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.